Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infused neutrophil dose and haematopoietic recovery in patients undergoing autologous transplantation.

× No keyword cloud information.

8 in total

1. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.

Authors: François Lefrère; Richard Delarue; Dominique Somme; Vincent Levy; Gandhi Damaj; Angela Tu; Raphael Porcher; Françoise Audat; Claire Boulat; Marine Cavazzana-Calvo; Agnès Buzyn; Coralie Belanger; Natacha Maillard; Olivier Hermine; Bruno Varet
Journal: Transfusion Date: 2002-04 Impact factor: 3.157

2. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.

Authors: D S Allan; M Keeney; K Howson-Jan; J Popma; K Weir; M Bhatia; D R Sutherland; I H Chin-Yee
Journal: Bone Marrow Transplant Date: 2002-06 Impact factor: 5.483

Review 3. Peripheral blood progenitor cell transplantation.

Authors: Jan Jansen; James M Thompson; Michael J Dugan; Pamela Nolan; Michael C Wiemann; Ruemu Birhiray; P Jean Henslee-Downey; Luke P Akard
Journal: Ther Apher Date: 2002-02

4. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.

Authors: M V Lioznov; P Freiberger; N Kröger; A R Zander; B Fehse
Journal: Bone Marrow Transplant Date: 2005-05 Impact factor: 5.483

5. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

Authors: David A Hess; Louisa Wirthlin; Timothy P Craft; Phillip E Herrbrich; Sarah A Hohm; Ryan Lahey; William C Eades; Michael H Creer; Jan A Nolta
Journal: Blood Date: 2005-11-03 Impact factor: 22.113

6. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.

Authors: C Hicks; R Wong; A Manoharan; Y L Kwan
Journal: Ann Hematol Date: 2007-05-10 Impact factor: 3.673

7. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations.

Authors: E Foïs; M Desmartin; S Benhamida; F Xavier; V Vanneaux; D Rea; J-P Fermand; B Arnulf; N Mounier; M Ertault; J-P Lotz; L Galicier; E Raffoux; M Benbunan; J-P Marolleau; J Larghero
Journal: Bone Marrow Transplant Date: 2007-08-27 Impact factor: 5.483

8. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.

Authors: C H Weaver; B Hazelton; R Birch; P Palmer; C Allen; L Schwartzberg; W West
Journal: Blood Date: 1995-11-15 Impact factor: 22.113

8 in total